Company / Financials
Dexcom Financials
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableRevenue
$4.7B
FY2025 · +15.6% YoY
Net Income
$836.3M
FY2025 · +45.1% YoY
Profit Margin
17.9%
FY2025 · net income / revenue
ROE
30.5%
FY2025 · return on equity
Total Assets
$6.3B
FY2025
Total Debt
-
FY2025
Equity
$2.7B
FY2025
ROA
13.2%
FY2025 · return on assets
Statement paths
Financial highlights
Key Data Points
- High earnings quality (cash-backed earnings)
- Strong return on equity: 26.4%
Data sourced from SEC EDGAR filings. Not investment advice.
Metric history
Revenue HistoryTotal revenue from operations$4.7B+15.6% YoYNet Income HistoryProfit after all expenses and taxes$836.3M+45.1% YoYGross Profit HistoryRevenue minus cost of goods sold$2.8B+14.9% YoYCost of Revenue HistoryDirect costs of producing goods and services sold$1.9B+16.6% YoYOperating Income HistoryProfit from core business operations before interest and taxes$911.8M+52.0% YoYSG&A Expense HistorySelling, general, and administrative expenses$1.3B+0.4% YoYR&D Expense HistoryResearch and development spending$599.1M+8.5% YoYInterest Expense HistoryCost of borrowing and debt obligations$14.3M-4.0% YoYIncome Tax HistoryTotal income tax expense$252.1M+89.8% YoYEPS (Basic) HistoryBasic earnings per share$2.14+46.6% YoY